...
首页> 外文期刊>Auris, nasus, larynx >Simultaneous metastasized primary unknown signet ring cell carcinoma of the cervical lymph node and mucoepidermoid carcinoma of the parotid gland as double cancers
【24h】

Simultaneous metastasized primary unknown signet ring cell carcinoma of the cervical lymph node and mucoepidermoid carcinoma of the parotid gland as double cancers

机译:同时转移的宫颈淋巴结和腮腺腺苷癌的颈淋巴结腺癌作为双癌

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Lymph node metastasis from signet ring cellcarcinoma (SRCC) primary unknown is extremely rare. We here report a case of primary-unknown SRCC that metastasized to the cervical lymph nodes, coexisting with mucoepidermoid carcinoma (MEC) of the parotid gland as a simultaneous double cancer. A 68-year-old female patient with right swollen cervical lymph nodes consulted our medical center. A diagnosis of bilateral cervical lymph node metastasis and a right parotid tumor was made. After bilateral neck dissection and right parotidectomy, the pathological diagnosis was SRCC of primary unknown with metastasis to the cervical lymph node and MEC of the parotid gland. Examination of the CRTC1/3-MAML2 fusion gene showed no relation between SRCC of primary unknown with metastasis to the cervical lymph node and MEC of the parotid gland. Ten months after the first treatment, there was recurrence in the left neck lymph node, and left neck dissection was performed. Fourteen months after the first treatment, the patient is alive and cancer-free. This case is the fourth report of SRCC with lymph node metastasis, and highlights the value of fusion gene detection to determine relatedness between simultaneous cancers. Moreover, such cases should be closely monitored for the subsequent appearance of distant metastases. (C) 2019 Elsevier B.V. All rights reserved.
机译:淋巴结转移来自标志戒指细胞外科(SRCC)主要未知是极少数的。我们在这里举报了对宫颈淋巴结转移的主要未知SRCC的情况,与腮腺的粘膜皮膜(MEC)共存作为同时双癌。一个68岁的女性患者患有右肿瘤颈淋巴结咨询了我们的医疗中心。制备双侧宫颈淋巴结转移和右腮腺肿瘤的诊断。双侧颈部解剖和右腮腺切除术后,病理诊断是对宫颈淋巴结和腮腺的MEC转移的原发性未知的SRCC。 CRTC1 / 3-MAML2融合基因的检测显示,METRASTASS与耳环淋巴结和腮腺的MEC转移的MRCC之间没有关系。在第一次治疗后十个月,左颈淋巴结的复发,并进行左颈部清除。第一次治疗后十四个月,患者活着和无癌症。这种情况是具有淋巴结转移的SRCC的第四次报告,突出了融合基因检测的价值,以确定同时癌症之间的相关性。此外,应密切监测这种情况,以便随后的远处转移出现。 (c)2019年Elsevier B.V.保留所有权利。

著录项

  • 来源
    《Auris, nasus, larynx》 |2020年第1期|共5页
  • 作者单位

    Tokyo Med Univ Hachioji Med Ctr Dept Otorhinolaryngol Head &

    Neck Surg 1163 Tatemachi Hachioji;

    Tokyo Med Univ Hachioji Med Ctr Dept Otorhinolaryngol Head &

    Neck Surg 1163 Tatemachi Hachioji;

    Tokyo Med Univ Hachioji Med Ctr Dept Clin Oncol 1163 Tatemachi Hachioji Tokyo 1930998 Japan;

    Tokyo Med Univ Hachioji Med Ctr Dept Pathol 1163 Tatemachi Hachioji Tokyo 1930998 Japan;

    Tokyo Med Univ Hachioji Med Ctr Dept Pathol 1163 Tatemachi Hachioji Tokyo 1930998 Japan;

    Tokyo Med Univ Hachioji Med Ctr Dept Otorhinolaryngol Head &

    Neck Surg 1163 Tatemachi Hachioji;

    Tokyo Med Univ Hachioji Med Ctr Dept Otorhinolaryngol Head &

    Neck Surg 1163 Tatemachi Hachioji;

    Tokyo Med Univ Hachioji Med Ctr Dept Otorhinolaryngol Head &

    Neck Surg 1163 Tatemachi Hachioji;

    Tokyo Med Univ Hachioji Med Ctr Dept Otorhinolaryngol Head &

    Neck Surg 1163 Tatemachi Hachioji;

    Tokyo Med Univ Hachioji Med Ctr Dept Otorhinolaryngol Head &

    Neck Surg 1163 Tatemachi Hachioji;

    Tokyo Med Univ Dept Otorhinolaryngol Head &

    Neck Surg Shinjuku Ku 6-7-1 Nishishinjuku Tokyo;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 耳鼻咽喉科学;
  • 关键词

    CRTC1/3-MAML2 fusion oncogene; Mucoepidermoid carcinoma; Signet ring cell carcinoma;

    机译:CRTC1 / 3-MAML2融合癌基因;粘膜脂蛋白癌;标志性戒指细胞癌;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号